RAUF-E 500MG/250MG TABLET
By Rauf-E
Rx
10 Tablet in a Strip

Composition
Tranexamic Acid(500mg) + Ethamsylate(250mg)

Manufacturer - Alna Biotech Pvt Ltd
Alna Biotech Private Limited, Jagjit Singh(Director), S. C. F - 1013, Ground Floor, Motor Market,. Mani Majra, Chandigarh - 160101, India

Expires on or after
September, 2026

liver
When it comes to using RAUF-E 500MG/250MG TABLET in patients with liver disease, it is considered to be safe based on the limited data available. It is suggested that no dose adjustment for RAUF-E 500MG/250MG TABLET is necessary in these patients. However, it is always best to consult your doctor before starting any medication, especially if you have liver issues. Your doctor will be able to provide you with the most appropriate guidance and ensure your safety.

kidney
RAUF-E 500MG/250MG TABLET needs caution in patients with kidney disease. Dosage adjustment may be necessary. Consult your doctor for guidance.

alcohol
RAUF-E 500MG/250MG TABLET can lead to extreme drowsiness when taken with alcohol. It is important to avoid alcohol while using this medication.

driving
RAUF-E 500MG/250MG TABLET typically does not impact driving ability.

pregnancy
Information about using RAUF-E 500MG/250MG TABLET during pregnancy is not available. It is advisable to consult your doctor for guidance.

breastfeeding
It is better to consult your doctor before using RAUF-E 500MG/250MG TABLET during breastfeeding.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | BLOOD RELATED |
| Action Class | - |
₹123.25
₹145
15% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025
